Nnyocha ọhụrụ: COVID-19 ịgba ọgwụ mgbochi ọrịa 90% dị irè megide Omicron

Ọmụmụ ihe ọhụrụ: COVID-19 ịgba ọgwụ mgbochi ọrịa 90% dị irè megide Omicron
Ọmụmụ ihe ọhụrụ: COVID-19 ịgba ọgwụ mgbochi ọrịa 90% dị irè megide Omicron

Ndị America kwesịrị inweta nkwalite ma ọ bụrụ na opekata mpe ọnwa ise agafeela kemgbe ha dechara usoro Pfizer ma ọ bụ Moderna, mana ọtụtụ nde ndị tozuru etozu enwetabeghị ha.

Print Friendly, PDF & Email

Ọmụmụ ọhụrụ atọ nke US Ụlọ Ọrụ Maka Nchịkwa na Mgbochi Ọrịa (CDC) kpughere na ogbunigwe Pfizer-BioNTech na Moderna dị irè 90% na-egbochi ndị mmadụ n'ụlọ ọgwụ mgbe ha nwechara ụdị Omicron nke nje COVID-19.

Usoro onunu ogwu a gosiputara nke oma n'igbochi omicron-metụtara ụlọ ọgwụ, dị ka CDC.

Jabs booster dịkwa 82% dị irè na igbochi ngalaba mberede na nleta nlekọta ngwa ngwa, data nyocha gosiri.

Nchọpụta ahụ nwere nnukwu ọmụmụ US mbụ iji leba anya na nchedo ọgwụ mgbochi omicron, ndị ọrụ ahụike kwuru.

"Ndị America kwesịrị inweta nkwado ma ọ bụrụ na ọ dịkarịa ala ọnwa ise agafeela kemgbe ha dechara usoro Pfizer ma ọ bụ Moderna, mana ọtụtụ nde ndị tozuru etozu enwetabeghị ha," CDC's Emma Accorsi, otu n'ime ndị odee ọmụmụ kwuru.

Akwụkwọ akụkọ ahụ kwughachiri nyocha gara aga - gụnyere ọmụmụ na Germany, South Africa na United Kingdom - na-egosi ọgwụ mgbochi ndị dịnụ adịghị arụ ọrụ megide Omicron karịa ụdị mbụ nke coronavirus, mana nke ahụ na-akwalite ọgwụ mgbochi nje na-alụ ọgụ iji nwekwuo ohere ịzere. ọrịa symptomatic.

Print Friendly, PDF & Email

Akụkọ ndi ozo

Banyere chepụtara

Harry Johnson

Harry Johnson bụ onye nchịkọta ọrụ maka eTurboNews maka mroe karịa afọ 20. O bi na Honolulu, Hawaii, ma o si Europe. Ọ na-amasị ya ide na ikpuchi akụkọ.

Ahapụ a Comment